Best Oral Presentations (OP01–OP12)

Feb 2012

Article PDF cannot be displayed. You can download it here:

https://academic.oup.com/rheumatology/article-pdf/51/suppl_1/i15/5178256/ker437.pdf

Best Oral Presentations (OP01–OP12)

i15 AUTHOR ABSTRACTS BEST ORAL PRESENTATIONS (OP01–OP12) OP01. ATHEROSCLEROSIS IN ANKYLOSING SPONYLITIS: THE RELATION WITH METHYLENETETRAHYDROFOLATEREDUCTASE (C677T) GENE POLYMORPHISIM AND PLASMA HOMOCYSTEINE LEVELS Muharrem Geçene1, Figen Tuncay1, Pınar Borman1, Doğan Yücel2, Mehmet S° enes2 and Bedriye KaniyeYılmaz3 1 Ankara Training and Research Hospital 1st Clinic of Physical Medicine and Rehabilitation, Ankara, Turkey, 2Ankara Training and Research Hospital Clinic of Biochemistry, Ankara, Turkey, 3Ankara Training and Research Hospital Department of Radiology, Ankara, Turkey Background: The aim of this study was to determine the intima-media thickness (IMT) as an indicator of subclinical atherosclerosis in carotid arteries and to assess the relation of these values with homocystein levels and Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism in patients with AS. Methods: Fifty male AS patients and 50 controls were included in the study. Serum lipids, vitamin B12, folic acid, homocystein and acute phase protein levels were measured in all cases. A plasma homocystein level of > 17 mmol/L was considered as hyperhomocysteinemia. MTHFR C677T gene polymorphisms were determined and IMT of main carotid artery were evaluated ultrasonographically in all subjects. BASDAI, ASDAS and BASMI were used to assess disease activity and spinal mobility. The relationship between plasma homocystein level, MTHFR C677T gene polymorphism, IMT values and clinical characteristics were determined. Results: Fifty AS patients (mean age of 36.6  4.79 years) and 50 control subjects (36.34  4.72 years) were included to the study. Demographic characteristic were smiliar between the groups. Plasma homocystein levels of AS patients and control group were also smiliar (14.26  9.96 vs 11.81  5.53 mmol/L). Hyperhomocysteinemia was present in 11 subjects in patient group (%22.0), while it was seen in 5 subjects in the control group (%10.0), and MTHFR C677T genotype distribution was CC 31 (%62), CT 14 (%28), TT 5 (%10) in AS patients and CC 26 (%52), CT 22 (%44), TT 2 (%4) in the control group, with no significant difference between groups (p ¼ 0.102, p ¼ 0.174) and the mean carotid IMT values were found to be similar between the groups. No relation was found between plasma homocystein levels and clinical and demographical properties. The most important factor influencing homocystein level was found as MTHFR 677TT genotype, which was established to increase the risk of hyperhomocyteinemia risk by 11.308 fold. Conclusions: In the present study, carotid IMT values, indicating subclinical atherosclerosis, were found to be similar in AS and control groups. The increase in the risk of atherosclerosis in AS patients seems not be different from healthy subjects. Disclosure statement: None. OP02. ADENOSINE MODULATION OF THE PRO-FIBROGENIC CYTOKINE IL-13 OCCURS VIA THE A2A ADENOSINE RECEPTOR Lisa Franks, Ross Radusky, Jessica Feig, Patricia Fernandez, Bruce Cronstein and Edwin Chan New York University School of Medicine, New York, NY, USA. Background: Our prior observations showed that the nucleoside adenosine and its receptor mediate collagen production and dermal fibrosis by human dermal fibroblasts in vitro. In addition, we showed that IL-13 expression is upregulated in tissues characterized by high levels of adenosine in the adenosine deaminase-deficient mouse model. This suggests adenosine upregulates the pro-fibrogenic cytokine IL-13. However, the receptor(s) and mechanism involved in this upregulation remained unknown. The aim of this study was to characterize further the contributions of endogenous adenosine and adenosine A2A receptors to skin fibrosis. Methods: In an in vitro study of cultured normal human dermal fibroblasts, the effect of adenosine A2A receptor modulation on IL-13 expression was studied. Using both the A2A receptor agonist (CGS21680, 1mM) and antagonist (ZM241385, 1mM), levels of IL-13 and IL-13 receptors were tested. Measurements of mRNA for IL-13 and three IL-13 receptor proteins, IL-13Ra1, IL-13Ra2 and IL-4 were assessed using real-time PCR amplification. Results: The A2A agonist induced elevated expression of message for IL-13 and two of three IL-13 receptors: IL-13Ra1 and IL-13Ra2. A 5fold increase in expression was found for IL-13Ra1 and a more modest 1.8-fold increase in IL-13Ra2. These inducible elevations were blocked by coincubation with the A2A receptor antagonist but not by antagonists to other adenosine receptors. Incubation with the A2A receptor antagonist alone did not affect the expression of IL-13 or its receptors. Conclusion: Despite efforts at investigating the mechanisms underlying fibrogenic processes in the skin of patients with scleroderma, no effective antifibrotic therapy exists. The nucleoside adenosine induces expression of pro-fibrotic cytokine IL-13 and particularly its cognate receptor IL-13Ra1.These findings suggest that blockade of the A2A receptor may be useful as a novel therapeutic agent to modify dermal fibrosis in scleroderma. Disclosure: E.C. & B.C. hold a patent on the use of A2A antagonists in fibrosis. OP03. THE ROLE OF STROMAL CELL-DERIVED FACTOR-1 IN ENDOCHONDRAL OSSIFICATION AND PATHOGENESIS OF OSTEOARTHRITIS Gunwoo Kim1,2,3, Seungwoo Han1,2, Yeonkwan Jung2, Shirine E Usmani3, Veronica Ulici3 and Frank Beier3 1 Division of Rheumatology, Department of Internal Medicine, Daegu Fatima Hospital, Daegu, South Korea, 2Laboratory for arthritis and bone biology, Fatima research institute, Daegu Fatima Hospital, Daegu, South Korea, 3CIHR Group in Skeletal Development and Remodeling, Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario, Canada Background: Changes of endochondral ossification in the articular cartilage, such as chondrocyte proliferation, differentiation and apoptosis, are thought to play an important role in the development of osteoarthritis. Understanding the molecular mechanisms controlling the endochondral ossification thus is important to understanding the pathogenesis of osteoarthritis. SDF-1a and aberrant endochondral ossification have been implicated in the pathogenesis of osteoarthritis, but how these processes are connected is unclear. In this study, we investigated the roles of SDF-1a on the endochondral ossification in mice. Methods: Primary chondrocytes and tibial explants from embryonic 15.5 day-old mice were cultured with SDF-1a to assess the roles of SDF-1a on the endochondral ossification. Total RNA was isolated from primary cell cultures using a Qiagen RNeasy Mini Kit. Real-time PCR analysis was performed using Applied Biosystems 7900 HT Real-Time PCR System and TaqManÕ Gene Expression Assays. Organ culture tissues were stained with safranin O/fast green and alcian blue/alizarin red, and the immunohistochemistry was also performed. Results: In primary chondrocyte cultures, the expression of chondrocyte proliferation marker, aggrecan, was increased, and the (...truncated)


This is a preview of a remote PDF: https://academic.oup.com/rheumatology/article-pdf/51/suppl_1/i15/5178256/ker437.pdf
Article home page: https://academic.oup.com/rheumatology/article/51/suppl_1/i15/1829235

Best Oral Presentations (OP01–OP12), 2012, pp. i15-i18, Volume 51, Issue suppl_1, DOI: 10.1093/rheumatology/ker437